Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy

Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy

Aim: To determine the survival and prognostic factors of patients with primary fallopian tube cancer (PFTC) who had been treated with paclitaxel and carboplatin chemotherapy. Methods: The records of patients with PFTC who had been treated between 2002 and 2010, identified through the report of Chian...

Saved in:

書目詳細資料
Main Authors:	Kietpeerakool C., Srisomboon J., Phongsaranantakul S., Khunamornpong S., Cheewakriangkrai C., Sribanditmongkol N.
格式:	Article
語言:	English
出版:	Blackwell Publishing Asia 2014
在線閱讀:	http://www.ncbi.nlm.nih.gov/pubmed/24738123 http://www.scopus.com/inward/record.url?eid=2-s2.0-84898726959&partnerID=40&md5=bbfd866b688dafaa0650a602e5ddacad http://cmuir.cmu.ac.th/handle/6653943832/1723
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Adverse affects of paclitaxel and carboplatin combination chemotherapy in epithelial gynecologic cancer
由: Kietpeerakool C., et al.
出版: (2014)

Adverse affects of paclitaxel and carboplatin combination chemotherapy in epithelial gynecologic cancer
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer
由: Kietpeerakool C., et al.
出版: (2014)

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
由: Lee, Matilda X, et al.
出版: (2021)

Primary carcinoma of the fallopian tube: A clinicopathologic analysis of 27 patients
由: Kietpeerakool C., et al.
出版: (2014)

Primary carcinoma of the fallopian tube: A clinicopathologic analysis of 27 patients
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Symptom Clusters in Thai Gynecological Oncology Patients Receiving the First Cycle of Carboplatin and Paclitaxel
由: Bualuang Sumdaengrit, et al.
出版: (2022)

Primary carcinoma of the fallopian tube
由: S. Senapad
出版: (2018)

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
由: Tony S. Mok, et al.
出版: (2018)

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
由: Tony S. Mok, et al.
出版: (2018)

The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients
由: Primandono Perbowo, -, et al.
出版: (2019)

Ultrasound appearance of fallopian tube carcinoma
由: Sauwakon Ajjimakorn, et al.
出版: (2018)

Effects of paclitaxel and carboplatin on quality of life and survival in patients with advanced non-small-cell lung cancer
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-effectiveness analysis of sequential paclitaxel adjuvant chemotherapy for patients with node positive primary breast cancer
由: Supon Limwattananon, et al.
出版: (2018)

Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy
由: Back, M.F., et al.
出版: (2016)

Bilateral primary carcinoma of the fallopian tubes. A case report
由: S. Toongsuwan, et al.
出版: (2018)

Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma.
由: Suprasert P., et al.
出版: (2014)

Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma
由: Suprasert P., et al.
出版: (2014)

Outcome of single agent generic gemcitabine in platinum- resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma
由: Suprasert P., et al.
出版: (2014)

Fluoroscopy-guided, transcervical, selective salpingography and fallopian tube recanalisation
由: Anil, G., et al.
出版: (2016)

Second primary malignancies in females with primary fallopian tube cancer
由: Riska, A., et al.
出版: (2014)

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
由: Dhammapoj Jeerakornpassawat, et al.
出版: (2020)

Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma
由: Prapaporn Suprasert, et al.
出版: (2018)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin.
由: Sirichaisutdhikorn D., et al.
出版: (2014)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
由: Sirichaisutdhikorn D., et al.
出版: (2014)

Evidence of chlamydial infection in infertile women with fallopian tube obstruction
由: Sharma M., et al.
出版: (2018)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
由: Daranee Sirichaisutdhikorn, et al.
出版: (2018)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
由: Daranee Sirichaisutdhikorn, et al.
出版: (2018)

The Differences of Apoptosis Effects Between Combination of Meloxicam with Gemcitabine-Carboplatin Chemotherapy Compared to Gemcitabine-Carboplatin Chemotherapy Alone in Urothelial Carcinoma Culture Cells
由: Ananta Cahyo Nugroho, et al.
出版: (2019)

Remission of recurrent cervical cancer with paclitaxel and carboplatin: A case report and review of literature
由: W. Termrungruanglert, et al.
出版: (2018)

Outcomes with single agent LIPO-DOX in platinum-resistant ovarian and fallopian tube cancers and primary peritoneal adenocarcinoma - Chiang Mai University Hospital experience
由: Suprasert P., et al.
出版: (2014)

Two-year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial
由: Imjai Chitapanarux, et al.
出版: (2020)

Sperm capacitation in the fallopian tube of the hamster and its suppression by endocrine factors
由: P. Viriyapanich, et al.
出版: (2018)

Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide
由: Shih, V., et al.
出版: (2014)

Intravenous versus oral regimens of dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in primary ovarian, fallopian tube and peritoneal cancer patients: a double-blind randomized controlled trial
由: Marut Yanaranop
出版: (2015)

Primary carcinoma of the fallopian tube: a 20-year review at Ramathibodi Hospital.
由: Y. Bhamarapravati, et al.
出版: (2018)